Overview

Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and safety of BTDS compared to placebo in subjects with moderate to severe low back pain.
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma K.K.
Treatments:
Buprenorphine